February 20, 2008 - Siemens Healthcare announces an exclusive partnership with Prowess Inc. to develop advanced radiation oncology treatment planning software for integration into Siemens' linear accelerators.

This agreement authorizes Siemens Healthcare to share the basic intellectual property of Prowess' patented Direct Aperture Optimization (DAO) planning software, allowing Siemens to incorporate Prowess’ software into the treatment planning tools for its linear accelerators, which, according to Siemens, will help users to reduce the number of segments, monitor units and treatment times.

The Prowess DAO-based Plan-to-Patient tool for Adaptive Radiation Therapy (ART) has been clinically evaluated and is planned to be available in the spring of 2008. The tool works with Siemens' CTVision System, a SOMATOM CT Sliding Gantry on rails combined with an ARTISTE or ONCOR Linear Accelerator. DAO reportedly enables users to make on-line plan corrections based on actual pre-treatment CT scans taken in the treatment room, while the patient is on the linear accelerator’s treatment table.

Siemens is also working on the development of a single arc radiation treatment called Cone Beam Therapy (CBT). The combination of CBT with DAO-based planning software will help improve tumor control for many disease sites, while sparing as much healthy tissue as possible, according to Siemens.

For more information: www.usa.siemens.com/healthcare


Related Content

News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
Feature | Radiation Oncology | By Christine Book

News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...

Time July 30, 2024
arrow
News | Radiation Oncology

July 11, 2024 — The American Society for Radiation Oncology (ASTRO) issued the following statement from Jeff M ...

Time July 11, 2024
arrow
News | Radiation Oncology

July 9, 2024 — Insights from the latest Mordor Intelligence report, “Radiotherapy Market Size & Share Analysis - Growth ...

Time July 09, 2024
arrow
News | Prostate Cancer

July 5, 2024 — Lantheus Holdings, Inc., a leading radiopharmaceutical-focused company committed to enabling clinicians ...

Time July 05, 2024
arrow
News | Radiology Business

July 3, 2024 — The American Society of Radiologic Technologists has launched the BeRAD Professionalism Award to ...

Time July 03, 2024
arrow
News | Prostate Cancer

July 2, 2024 — A new editorial paper was published in Oncoscience (Volume 11) on May 20, 2024, entitled, “Deep learning ...

Time July 02, 2024
arrow
News | Radiation Oncology

June 3, 2024 — The American Society for Radiation Oncology (ASTRO) published an updated clinical guideline that details ...

Time June 03, 2024
arrow
News | Oncology Information Management Systems (OIMS)

May 30, 2024 — RaySearch Laboratories AB announced the release of the latest version of RayCare, the next generation ...

Time May 30, 2024
arrow
Subscribe Now